Effects of botulinum toxin type a on mood and cognitive function in patients with parkinson’s disease and depression

Jan 18

Written by Sebastian De Beurs

Sebastian De Beurs

The safety and efficacy of botulinum toxin A on the treatment of depression

OnabotulinumtoxinA for the treatment of major depressive disorder: a phase 2 randomized, double-blind, placebo- controlled trial in adult females